ReviewStem cell reviews and reports2016
Social Responsibility in Stem Cell Research - Is the News All Bad?
Review in Stem cell reviews and reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Enhancing translational medical research through proof-of-concept services: clinicians' perspectives.Scientific reports · 2024Article
- Clinical translation of tissue-engineered oesophageal grafts: are patients ready for us?Pediatric surgery international · 2024Article
- Overcoming barriers to facilitate the regulation of multi-centre regenerative medicine clinical trials.Stem cell research & therapy · 2018Review
- Reflections on translation: Views of participants in a multisite Canadian CCSVI clinical trial.Neurology. Clinical practice · 2018Review
- Resilience, trust, and civic engagement in the post-CCSVI era.BMC health services research · 2018Article
- Blood-brain barrier and foetal-onset hydrocephalus, with a view on potential novel treatments beyond managing CSF flow.Fluids and barriers of the CNS · 2017Review
- A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine.NPJ Regenerative medicine · 2017Review
- A Dichotomy of Information-Seeking and Information-Trusting: Stem Cell Interventions and Children with Neurodevelopmental Disorders.Stem cell reviews and reports · 2016Article
- Perspectives About Time Frames in Stem Cell Research for Multiple Sclerosis: "Time Is Brain".International journal of MS careArticle
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Transparent public discourse about translational stem cell research promotes informed hope about scientific progress and the sustainable development of biotechnologies. Using an a priori coding scheme, we surveyed articles from leading news media about stem cell interventions for neurodegenerative diseases (1991-2014) from United States (n = 83), Canada (n = 29), and United Kingdom (n = 65). While, this analysis of translational contexts in the news demonstrates a lingering tendency to celebrate the benefits of research with little context of its caveats even for chronic neurologic diseases, in a departure from many previous studies, the data also reveal conscientious reporting about stem cell tourism and timeframe estimates for the development of relevant therapeutics.
Indexed as
Identifiers
26815726What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.